ClinicalTrials.Veeva

Menu

Sound Processing Changes in Babies With Opioid Exposure

University of Rochester logo

University of Rochester

Status

Completed

Conditions

Neonatal Abstinence Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT03567603
RSRB#72329

Details and patient eligibility

About

The purpose of this study is to identify problems with interpreting sounds in babies that have been exposed to opioids prior to birth. Being able to identify these issues in infancy may allow us to find children who may have problems with language learning later in life so that we can try to minimize these.

Full description

This is a single center prospective study of neonates >36 weeks' gestation prenatally exposed to psychoactive substances and gestationally age-matched controls. Evoked response potentials on EEG in response to auditory oddball paradigms will be compared between cohorts. Analyses will try to identify differences in auditory processing using ANOVAs to compare the mismatch negativity measures, amplitudes and latencies as a function of study group.

Enrollment

37 patients

Sex

All

Ages

Under 20 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age ≥ 36 weeks, confirmation of dates via ultrasound or last menstrual period
  • Prenatal opioid exposure ("exposed"), confirmed via admitted use or newborn drug screen; no prenatal opioid exposure ("control") by maternal report or testing
  • All races, ethnicities, sexes to be included
  • Informed permission form signed by mother

Exclusion criteria

  • Birth weight ≤ 3rd percentile or ≥ 97th percentile for gestational age
  • Have comorbid medical disorders including; those associated with sensorineural hearing loss, significant congenital anomalies, congenital heart disease, known brain injury/malformations
  • Infants requiring mechanical ventilation
  • Infants requiring continuous sedation

Trial design

37 participants in 2 patient groups

opioid exposed neonates
Description:
prenatal opioid exposure
non-opioid exposed neonates
Description:
no prenatal opioid exposure

Trial contacts and locations

1

Loading...

Central trial contact

John Foxe, PhD; Ronnie Guillet, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems